AR-V7 in Asian patients with metastatic CRPC: A multinational, multicentre study.

Authors

null

Hui Shan Tan

National Cancer Centre Singapore, Singapore, Singapore

Hui Shan Tan , Alvin Seng Cheong Wong , Kian Tai Chong , Siew Wei Wong , Marniza Bte Saad , Chi-Fai Ng , Shigeo Horie , Phichai Chansriwong , Min-Han Tan , Chee-Keong Toh , Quan Sing Ng , Kiat Hon Lim , Liang Seah Tay , Whee Sze Ong , Ravindran Kanesvaran

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 Genitourinary Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session B: Prostate Cancer, Urothelial Carcinoma, and Penile, Urethral and Testicular Cancers

Track

Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers

Sub Track

Prostate Cancer - Advanced Disease

Citation

J Clin Oncol 36, 2018 (suppl 6S; abstr TPS401)

DOI

10.1200/JCO.2018.36.6_suppl.TPS401

Abstract #

TPS401

Poster Bd #

M21

Abstract Disclosures

Similar Posters

Poster

2015 Genitourinary Cancers Symposium

AR splice variant 7 (AR-V7) and response to taxanes in men with metastatic castration-resistant prostate cancer (mCRPC).

AR splice variant 7 (AR-V7) and response to taxanes in men with metastatic castration-resistant prostate cancer (mCRPC).

First Author: Emmanuel S. Antonarakis

First Author: Karim Fizazi

First Author: Benedito A. Carneiro